Use the Search Fields to Find Information
Page 10 of 339
Unmet Healthcare Needs and Medical Cannabis Use Among Sexual and Gender Minoritized Adults in a High-Stigma Environment
Please use this link to access this publication. ABSTRACT Sexual and gender minoritized (SGM) individuals in high-stigma areas may use cannabis to cope with unmet
March 3, 2025
Unlocking the Healing Potential Cannabinoids in Spine Surgery for Pain Relief and Recovery
Please use this link to access this publication: https://journals.lww.com/jbjsreviews/abstract/2023/11000/unlocking_the_healing_potential__cannabinoids_in.4.aspx Abstract » Cannabinoids, such as D9-tetrahydrocannabinol and cannabidiol, interact with endocannabinoid receptors in the central nervous system
December 6, 2023
United States patent application publication for phytocannabinoids in the treatment of cancer
This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug sub stance (BDS) in
September 19, 2019
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
Abstract Alzheimer’s disease (AD), the most common neurodegenerative disease, is characterized by progressive cognitive impairment. The deposition of amyloid beta (Aβ) and hyperphosphorylated tau is
April 19, 2024
Understanding Older Adults’ Experiences with Cannabis for Medicinal Purposes: A Mixed Methods Study
Abstract The aim of this study was to explore the perspectives of older medicinal cannabis consumers and those advising them on older Canadians’ experiences accessing
April 17, 2025
Understanding cancer survivors’ reasons to medicate with cannabis: A qualitative study based on the theory of planned behavior
Abstract Background Prior to nonmedical cannabis legalization in Canada, individuals were only able to access cannabis legally through licensed producers with medical authorization. Now with
June 13, 2025
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
Fragile X syndrome, the most commonly known genetic cause of autism, is due to loss of the fragile X mental retardation protein, which regulates signal
September 19, 2019
UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia
Abstract Introduction The primary aim of this study was to assess changes in sleep-specific health-related quality of life (HRQoL) for those prescribed cannabis-based medicinal products
December 17, 2024
UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders
ABSTRACT Objectives Headache disorders are a common cause of disability and reduced health-related quality of life globally. Growing evidence supports the use of cannabis-based medicinal
October 3, 2024
Page 10 of 339